A 28 year old man presented with a 1 month history of symptoms of intracranial hypertension. Examination showed bilateral papilloedema and meningeal signs. Magnetic resonance imaging showed nodular lesions on the cerebellar and pontine surface and thickening of the thoracic spinal leptomeninges. Throughout the course of the disease, contrast enhancement was detected in the spinal leptomeninges but not intracranially. Primary diffuse leptomeningeal gliomatosis (PDLG) was diagnosed by biopsy and later confirmed on necropsy. The present case is remarkable for the nodular superficial cerebellar lesions and the absence of intracranial contrast enhancement of the leptomeninges.
- primary diffuse leptomeningeal gliomatosis
- chronic meningitis
- magnetic resonance imaging
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Glioma arising primarily from the leptomeninges is extremely rare and often is diagnosed only on postmortem examination. It is thought to derive from heterotopic nests of neuroglial tissue within the leptomeninges, which are present in 1% of necropsies.1 Primary leptomeningeal glioma can be in the form of a solitary tumour or a diffuse tumour involving intracranial or spinal cord leptomeninges.2 3Leptomeningeal gadolinium enhancement was positive in all cases of primary leptomeningeal glioma in which MRI was applied (eight cases on record).4-11 Brain MRI with gadolinium contrast enhancement is therefore considered the imaging modality of choice for the early detection of this condition.9 We report a case of primary diffuse leptomeningeal gliomatosis established by necropsy with the unusual MRI findings of nodular superficial cerebellar lesions and the absence of intracranial contrast enhancement of the leptomeninges.
In December 1997, a previously healthy 28 year old man developed frontal headaches. From January 1998, the headaches were accompanied by nausea and vomiting. He became somnolent and was admitted to the Bezirkskrankenhaus Gabersee. On admission he was apathetic, confused, and had a slight neck stiffness. Otherwise, his neurological examination was normal; in particular he had no signs of spinal cord dysfunction. The patient was afebrile, and the blood chemistry results were normal. Cranial MRI showed multiple nodular hyperintensities (T2 weighted images, fig 1) on the cerebellar and pontine surface without any contrast enhancement (T1 weighted images, fig 1). The last follow up MRI with application of contrast medium was performed at the beginning of April. Until then, no intracranial contrast enhancement could be detected. On spinal MRI, leptomeningeal thickening and gadolinium enhancement were discernible from C7 to Th5 (fig 2). No lesion of the parenchyma of brain or spinal cord was detected on MRI then or later during the course of the disease. Analysis of CSF disclosed a pleocytosis of 30 cells/mm3 (mainly lymphocytes and monocytes, cytology showed no malignant cells), a raised protein value (4.2 g/l), and a glucose concentration of 2.55 mmol/l (glucose CSF/serum index 0.5); oligoclonal bands were negative. The findings suggested a CNS infection and a broad antiviral (aciclovir) and antibacterial therapy (ceftriaxone, fosfomycin, ampicillin), including antituberculous drugs (isoniazid, rifampin, pyrazinamide) was started. However, CSF microscopy and cultures and serological tests did not confirm an infection. Therefore, the antimicrobial therapy was discontinued after 2 weeks. At the beginning of February 1998, the patient was released home. One week later, the headache increased again and he was admitted to our Neurological Department. Examination was normal except for bilateral papillodema. Repeated spinal taps showed raised CSF protein concentrations (up to 10 g/l) and a pleocytosis (up to 20 cells/mm3; 20% lymphocytes, 35% monocytes, 45% macrophages). Immunotyping showed no immature or atypical cells. Opening pressures were raised (300 to 860 mm H2O) and were normalised by removal of 20-30 ml CSF, which greatly relieved the patient's headache. “Symptomatic” pseudotumour cerebri due to chronic meningitis was diagnosed and treated with repeated spinal taps. At the beginning of April 1998, the patient had a first grand mal seizure. Although phenytoin was started, the patient remained obtunded and his level of consciousness deteriorated to coma within hours. Both pupils were dilated and cranial CT showed discrete sulcal effacement of both cerebral hemispheres. A ventricular catheter was placed to measure intracranial pressure (ICP), which exceeded 40 mm Hg. After CSF drainage, osmotic therapy (mannitol and tris buffer), and hyperventilation, the patient regained consciousness within a few hours. Neurological status normalised except for left III and right VI cranial nerve palsy. A stereotactic biopsy of the surface of the cerebellum showed a leptomeningeal anaplastic astrocytoma corresponding to World Health Organisation (WHO) grade III. Two days after the biopsy, the patient had another episode of cerebral herniation with coma and wide, unresponsive pupils that required a decompressive craniotomy of the posterior fossa. Despite therapy, progressive brain swelling developed and the patient died after a 5 month course of illness.
Macroscopic postmortem examination showed diffuse tumour infiltration and thickening of the leptomeninges encasing the cervicothoracic spinal cord (fig 3 A), brain stem, and cerebellum. There was a superficial nodular infiltration of the cerebellum. No parenchymal tumour was detected in the cerebrum, cerebellum, or spinal cord. Macroscopic and microscopic examination showed no heterotopic glial tissue in the intracranial or spinal leptomeninges. Microscopy confirmed a cellular glioma growing diffusely within the leptomeninges and subarachnoid space. The nodules in the cerebellar leptomeninges and the spinal leptomeningeal tumour were comparable in composition. The tumour cells showed an astrocytic phenotype with medium sized ovoid nuclei and a faintly eosinophilic cytoplasm with multipolar fibrillary processes (fig 3 B). Multinucleated cells were occasionally seen. Mitotic activity was obvious whereas necrosis and microvascular proliferation were absent. In line with the macroscopic findings, tumour infiltration was restricted to the leptomeninges of the cervicothoracic spinal cord, brain stem, and cerebellum. A high percentage of tumour cells stained positive for glial fibrillary acidic protein on immunohistochemistry (fig 3 B). Neuronal markers (synaptophysin and neuron specific enolase) were negative. Therefore, the neuropathological diagnosis of primary diffuse leptomeningeal anaplastic astrocytoma (WHO grade III) was established.
We report on a patient with histologically (biopsy and necropsy) established PDLG who presented with a syndrome that was suggestive of chronic meningitis (headache, obtundation, neck stiffness, raised CSF protein and cell count, spinal leptomeningeal thickening, and contrast enhancement). The nodular lesions on the cerebellar surface caused us to suspect a parasitic infection such as echinococcosis or cysticercosis. However, the extensive search for an infectious aetiology was unsuccesful. Furthermore, repeated cytological CSF examination never showed malignant cells. Negative cytology seems to be a common finding in PDLG: only one of 24 cases on record had a positive cytology12 (retrieved by Medline and Pubmed search of English articles for the period 1966-99 and from publications cited therein). By contrast, eight of 12 patients with secondary meningeal tumour spread from intracranial malignant glioma were diagnosed antemortem by cytology.13 It remains unclear whether this discrepancy is due to a different biological behaviour of primary leptomeningeal gliomas or because CSF cytological examination is repeated less often or performed less thoroughly in PDLG than in patients with intracranial malignant glioma who are suspected to have secondary meningeal tumour spread. The neuroradiological findings of our case are remarkable, as a review of the literature showed that leptomeningeal thickening and contrast enhancement could be detected in six of eight cases of PDLG with cranial CT12 14-18 and in all eight cases with MRI (cranial and/or spinal).4-11Gadolinium enhanced MRI, therefore, was positive in all cases when applied, whereas contrast CT was read as negative in two of eight patients examined: in one patient no leptomeningeal enhancement was detected,19 and in the second enhancement was seen only retrospectively.20 Enhancement was either focal9 15 or, more often, diffuse in the spinal cord or brain.4-8 10-12 16-18 21 In addition to diffuse enhancement, small enhancing nodules of the spinal leptomeninges were reported in two cases.4 9 Nodular lesions, as seen in our patient, have not been reported so far. Furthermore, although the spinal tumour showed gadolinium enhancement, the intracranial tumour did not despite uniform histopathology. Therefore, contrast enhancement is not an obligatory feature of PDLG.
We thank Dr M Wick (Department of Clinical Chemistry), Dr W Stummer (Department of Neurosurgery), and Dr G Bachmann (Department of Neurology, Bezirkskrankenhaus Gabersee) for their cooperation. We also thank Ms J Benson for copyediting the manuscript.